Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019

SELL
$14.4 - $21.45 $1.44 Million - $2.15 Million
-100,000 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$16.51 - $51.33 $2.2 Million - $6.83 Million
-133,073 Reduced 57.09%
100,000 $1.92 Million
Q3 2018

Nov 14, 2018

SELL
$43.15 - $67.97 $2.89 Million - $4.55 Million
-66,927 Reduced 22.31%
233,073 $12.2 Million
Q2 2018

Aug 14, 2018

BUY
$35.06 - $51.17 $455,780 - $665,210
13,000 Added 4.53%
300,000 $13 Million
Q1 2018

May 15, 2018

BUY
$19.05 - $41.76 $1.38 Million - $3.03 Million
72,500 Added 33.8%
287,000 $10.6 Million
Q4 2017

Feb 14, 2018

SELL
$19.01 - $26.2 $484,755 - $668,100
-25,500 Reduced 10.63%
214,500 $4.26 Million
Q3 2017

Nov 14, 2017

BUY
$12.53 - $27.12 $3.01 Million - $6.51 Million
240,000
240,000 $5.97 Million

Others Institutions Holding GTHX

About G1 Therapeutics, Inc.


  • Ticker GTHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,746,800
  • Market Cap $306M
  • Description
  • G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...
More about GTHX
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.